Spectrum of SGLT2-Inhibitor Benefits: Clinical to Symptoms to Quality of Life
We Recommend
Disclosures
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:
- Consultant Fee/Honoraria/Speaker's Bureau (Personal) - AstraZeneca; Bayer AG; Abbott; Medtronic; Merck/Schering Plough; Adrenomed; Applied Therapeutics; Array; Boehringer Ingelheim; CVRx; G3 Pharma; Impulse Dynamics; Innolife; Janssen; LivaNova; Luitpold; Novartis; NovoNordisk; Relypsa; Sequana Medical; Vifor
- Grant Support/Research Contract (Personal) - Amgen